Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2011
https://www.valueinhealthjournal.com/article/S1098-3015(14)03941-2/fulltext
Title :
Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03941-2&doi=10.1016/j.jval.2014.08.2011
First page :
A588
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1475